Molecular Pharmaceutics
[ASAP] Placental Therapeutic Targets and Nanodelivery Systems
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00601
Molecular Pharmaceutics
[ASAP] Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian Cancer Cells
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00525
Molecular Pharmaceutics
[ASAP] Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex <italic toggle=”yes”>In Vitro</italic> and <italic toggle=”yes”>In Vivo</italic>
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00553
Molecular Pharmaceutics
[ASAP] Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00536
Molecular Pharmaceutics
[ASAP] Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled HZ20 Angiotensin-Converting Enzyme 2‑Targeting Peptides for Tumor-Specific Imaging
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00541
Molecular Pharmaceutics
[ASAP] Predicting Experimental <italic toggle=”yes”>B</italic><sub>22</sub> Values and the Effects of Histidine Charge States for Monoclonal Antibodies Using Coarse-Grained Molecular Simulations
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00337
Molecular Pharmaceutics
[ASAP] Fluorinated Hyaluronic Acid Encapsulated Perfluorocarbon Nanoparticles as Tumor-Targeted Oxygen Carriers to Enhance Radiotherapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00432
Molecular Pharmaceutics
[ASAP] Multi-Level High-Throughput Screening for Discovery of Ligands That Inhibit Insulin Aggregation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00219
Molecular Pharmaceutics
[ASAP] Mouse Bone Marrow Mesenchymal Stem Cells Inhibit Sepsis-Induced Lung Injury in Mice via Exosomal SAA1
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00542
Molecular Pharmaceutics
[ASAP] High-Contrast Detection of Somatostatin Receptor Subtype‑2 for Fluorescence-Guided Surgery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00583